Terry Colip currently serves as Founding Member, Managing Member, and Chief Financial Officer of Cell>Point. Based in Centennial, Colorado, Cell>Point is an innovative biotech company that focuses on developing intranuclear metallic therapeutics and universal imaging agents. Under the leadership of Terry Colip and a skilled team of biotech professionals, Cell>Point seeks to achieve significant advancements in the diagnosis and monitoring of diabetes, strokes, oncology, and cardiology. The technology platforms developed by Cell>Point hold licenses from The University of Texas MD Anderson Cancer Center.
Educated at the College of Engineering of the University of Wisconsin, Terry Colip earned his Bachelor of Science in Industrial Engineering in 1979. He continued his education at New York University, completing his MPA in Finance and Health Care Administration in 1981. Prior to establishing his career at Cell>Point, Terry Colip gained important industry knowledge as a Health Care Investment Banker with American Health Capital in New York. His past career experience also includes serving as a Health Care Consultant for Coopers & Lybrand and a Director of Health Care Finance for Boettcher & Company as well as Underwood, Neuhaus & Co.
As a longtime professional in the health care industry, Terry Colip actively contributes to organizations that support wellness in the community. His charitable activities include donating to children’s hospitals in the Denver area, as well as Rotary International, Families First, and Adam’s Camp for teens with disabilities. In his free time, he enjoys engaging in outdoor activities such as golfing, skiing, and traveling. Further information regarding Cell>Point and the current career of Terry Colip can be found online at www.cellpointweb.com.
